en
/
fr
Ethics Portal
Who We Are
Vision & Mission
Our Model
Strategy
Governance & Team
Governance Board
Expert Advisory Group
MPP Staff (A to Z)
Ethics Portal
Funding
Who We Work With
What We Do
Our Work
HIV
Hepatitis C
Tuberculosis
Paediatrics
Universal Health Coverage and Essential Medicines
COVID-19
Licence Overview
Products Licensed
Key features of MPP licences
Update on Progress
Other Partnerships
Expression of Interest
Target Medicines
Projections
Media
Press
Press Releases
Statements
Highlights
Endorsements
Features
Message from the Executive Director
‘First Person’ series
Dolutegravir – making a difference to people’s lives
MPP in the News
Events
Resources
MedsPaL
Publications
Annual Reports
MPP Publications
Related Publications
Projections
Newsletters
Documents
Resources Search
Contact
Annual Reports
Annual Reports
17 July 2019
2018 Annual Report: Expanding Access to Public Health
Annual Reports
24 May 2018
Annual Report 2017: Partnering for Development and Delivery
Annual Reports
22 May 2017
Annual Report 2016: Expanding for Better Treatment Options
Annual Reports
01 December 2015
Annual Report 2015: Five Years of Patent Pooling for Public Health
Annual Reports
01 December 2014
Annual Report 2014: Working Today for the Treatments of Tomorrow
Annual Reports
01 December 2013
Annual Report 2013: Building Partnerships, Accelerating Access
Annual Reports
20 July 2012
Annual Report 2012
Annual Reports
01 December 2011
Annual Report 2010-2011 – First annual report
Keywords
Resource Type
All
Annual Reports
Document
MPP Publications
Newsletter
Projections
Publication
Related Publication
Disease
All
Hepatitis C
HIV
TB
Search
Cookie Policy
This website uses cookies to ensure you get the best experience on our website.
Learn More
Decline
Allow Cookies
Annual Reports 
